[ad_1]
In recent days, the news that the German government has purchased 200,000 doses of two drugs that treat coronavirus has attracted a lot of attention.
Although these drugs have not yet been approved by the European Union health authorities, the Germans made this decision based on the approval of the US Food and Drug Administration (FDA).
The FDA, as one of the most important institutions in the world in the field of public health, issued an urgent approval for the use of these drugs in November, reconfirming their reliability.
Apparently that was enough for the Germans to take extra steps in the fight against the Corona Virus in order to protect their citizens, without waiting for registration from the European Medicines Agency EMA.
But this is not the only case, the FDA with its decisions has made a very significant contribution to solving public health problems.
Over the past year, the FDA has taken another decision that represents a milestone in the field of public health, after authorizing IQOS, an electronic device that heats but does not burn tobacco, as a “modified” risk product.
During 2019, when the mysterious lung disease emerged, which is suspected to have been caused by the use of unknown liquids for electronic cigarettes and by unreliable manufacturers, US authorities banned the use of vaping products in some countries. To keep the situation under control, the FDA invited all manufacturers of tobacco and nicotine products to apply for authorization of their products.
Also last July, the FDA issued a decision reaffirming confidence in credible alternatives to even science-based products. After nearly four years and analysis of just over two million pages of scientific research itself, the US agency has decided to classify IQOS, a system that heats but does not burn tobacco produced by Philip Morris, into the category of tobacco products that reduce significant exposure to harmful substances compared to cigarettes. Regarding the decision, the FDA states that the use of IQOS is in the public interest, while Mitch Zeller, director of the FDA Center for Tobacco Products, said that “the device can help adult smokers quit smoking and / or reduce their exposure to harmful substances, but only if they are fully absorbed in this product. ”
This decision offers a better opportunity for all non-smoking smokers to seek better, science-based alternatives.
top channel
[ad_2]
Source link
